I had the great opportunity today to address the National Academies of Science, Engineering, and Medicine’s committee on Equity Considerations in Injury Compensation. I discussed my more than 20 years experience in the National Vaccine Injury Compensation Program, how the NVICP evolved and how Congress’ failure to modernize the Program is causing crushing delays.
October 12, 2023 VIP Bar Association Board on the COVID-19 Vaccine lawsuit against HRSA The Vaccine Injured Petitioners (VIP) Bar...
Unfortunately, they're exactly what we expected. There was one payout for anaphylaxis ($2,019.55), and two myocarditis ($1,582.65 and...
The Countermeasures Program's (CICP), which has jurisdiction for all Covid-19 vaccine injuries, has a higher burden of proof than the...
Comments